Parecer de pré-exame
#6.23
05/12/2026
RPI 2888
Application data
Number
112022023368Type
Filing
Publication
PCT
EP2021063075 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 05/12/2026. We update with every new RPI gazette, published weekly.
Applicants
GENFIT
FR
Inventors
A. R. (pessoa física)
FR
IPC Classification
Priority claims
EP
20305513.2 · 05/18/2020
Abstract
ELAFIBRANOR PARA O TRATAMENTO DE COLANGITE ESCLEROSANTE PRIMÁRIA.A presente invenção se refere a elafibranor ou seu metabólito ativo para uso em um método de tratamento de colangite esclerosante primária.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
05/12/2026
RPI 2888
#1.3
12/20/2022
RPI 2711
#1.1
11/29/2022
RPI 2708
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.